Vaccination for pandemic influenza: a six point agenda for interpandemic years
Identifieur interne : 000A69 ( France/Analysis ); précédent : 000A68; suivant : 000A70Vaccination for pandemic influenza: a six point agenda for interpandemic years
Auteurs : David S. Fedson [France]Source :
- The Pediatric infectious disease journal [ 0891-3668 ] ; 2004.
Descripteurs français
- KwdFr :
- Calendrier vaccinal, Femelle, Flambées de maladies (), Grippe humaine (épidémiologie), Humains, Mise en oeuvre des programmes de santé, Mâle, Organisation mondiale de la santé, Politique de santé, Recommandations comme sujet, Santé mondiale, Sensibilité et spécificité, Vaccination (normes), Vaccins antigrippaux (administration et posologie).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- normes : Vaccination.
- épidémiologie : Grippe humaine.
- Pascal (Inist)
- Calendrier vaccinal, Femelle, Flambées de maladies, Humains, Immunoprophylaxie, Mise en oeuvre des programmes de santé, Mâle, Organisation mondiale de la santé, Politique de santé, Recommandations comme sujet, Santé mondiale, Sensibilité et spécificité, Vaccination, Grippe, Prévention, Santé publique, Vaccin, Homme.
- Wicri :
- topic : Vaccination, Santé publique, Vaccin, Homme.
English descriptors
- KwdEn :
- Disease Outbreaks (prevention & control), Female, Global Health, Guidelines as Topic, Health Plan Implementation, Health Policy, Human, Humans, Immunization Schedule, Immunoprophylaxis, Influenza, Influenza Vaccines (administration & dosage), Influenza, Human (epidemiology), Male, Prevention, Public health, Sensitivity and Specificity, Vaccination, Vaccination (standards), Vaccine, World Health Organization.
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- epidemiology : Influenza, Human.
- prevention & control : Disease Outbreaks.
- standards : Vaccination.
- Female, Global Health, Guidelines as Topic, Health Plan Implementation, Health Policy, Humans, Immunization Schedule, Male, Sensitivity and Specificity, World Health Organization.
Abstract
Background. The demand for influenza vac cine is driven by recognition of its health and economic benefits. Vaccine reduces all cause mortality in the elderly by 30 to 50% and prevents ≥30% of hospital admissions for influenza related respiratory disease, heart disease and stroke. However, because most influenza vaccine (85%) is produced in only eight countries, adequate production and equitable distribution of vaccine throughout the world will pose a serious challenge when the next influenza pandemic appears. Methods. This article reviews a six point agenda for pandemic vaccination that should be undertaken during interpandemic years. The agenda includes preparing vaccine seed strains using reverse genetics, determining the characteristics of a pandemic vaccine and vaccination schedule, considering global registration of pandemic vaccines, increasing vaccination in interpandemic years, documenting the epidemiology of vaccine use and addressing political issues that will affect the global supply of pandemic vaccines. Conclusions. Planning for pandemic vaccination must begin during the interpandemic period to ensure a vaccine supply that will be adequate to meet demand in all countries. This will require the skills not only of experts in virology, epidemiology and public health but also those in politics, economics and law. The task will be complex, but its promised benefits will be immense.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 001E15
- to stream PascalFrancis, to step Curation: 000086
- to stream PascalFrancis, to step Checkpoint: 001D22
- to stream Main, to step Merge: 005C32
- to stream PubMed, to step Corpus: 001F35
- to stream PubMed, to step Curation: 001F35
- to stream PubMed, to step Checkpoint: 001C81
- to stream Ncbi, to step Merge: 000119
- to stream Ncbi, to step Curation: 000119
- to stream Ncbi, to step Checkpoint: 000119
- to stream Main, to step Merge: 005A88
- to stream Main, to step Curation: 005843
- to stream Main, to step Exploration: 005843
- to stream France, to step Extraction: 000A69
Links to Exploration step
Pascal:04-0419609Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Vaccination for pandemic influenza: a six point agenda for interpandemic years</title>
<author><name sortKey="Fedson, David S" sort="Fedson, David S" uniqKey="Fedson D" first="David S." last="Fedson">David S. Fedson</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Pasteur Mérieux MSD</s1>
<s2>Sergy Haut</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>Sergy Haut</wicri:noRegion>
<wicri:noRegion>Pasteur Mérieux MSD</wicri:noRegion>
<wicri:noRegion>Pasteur Mérieux MSD</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0419609</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 04-0419609 INIST</idno>
<idno type="RBID">Pascal:04-0419609</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001E15</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000086</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001D22</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001D22</idno>
<idno type="wicri:doubleKey">0891-3668:2004:Fedson D:vaccination:for:pandemic</idno>
<idno type="wicri:Area/Main/Merge">005C32</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:14730273</idno>
<idno type="wicri:Area/PubMed/Corpus">001F35</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F35</idno>
<idno type="wicri:Area/PubMed/Curation">001F35</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001F35</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001C81</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001C81</idno>
<idno type="wicri:Area/Ncbi/Merge">000119</idno>
<idno type="wicri:Area/Ncbi/Curation">000119</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000119</idno>
<idno type="wicri:doubleKey">0891-3668:2004:Fedson D:vaccination:for:pandemic</idno>
<idno type="wicri:Area/Main/Merge">005A88</idno>
<idno type="wicri:Area/Main/Curation">005843</idno>
<idno type="wicri:Area/Main/Exploration">005843</idno>
<idno type="wicri:Area/France/Extraction">000A69</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Vaccination for pandemic influenza: a six point agenda for interpandemic years</title>
<author><name sortKey="Fedson, David S" sort="Fedson, David S" uniqKey="Fedson D" first="David S." last="Fedson">David S. Fedson</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Pasteur Mérieux MSD</s1>
<s2>Sergy Haut</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>Sergy Haut</wicri:noRegion>
<wicri:noRegion>Pasteur Mérieux MSD</wicri:noRegion>
<wicri:noRegion>Pasteur Mérieux MSD</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">The Pediatric infectious disease journal</title>
<title level="j" type="abbreviated">Pediatr. infect. dis. j.</title>
<idno type="ISSN">0891-3668</idno>
<imprint><date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">The Pediatric infectious disease journal</title>
<title level="j" type="abbreviated">Pediatr. infect. dis. j.</title>
<idno type="ISSN">0891-3668</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Disease Outbreaks (prevention & control)</term>
<term>Female</term>
<term>Global Health</term>
<term>Guidelines as Topic</term>
<term>Health Plan Implementation</term>
<term>Health Policy</term>
<term>Human</term>
<term>Humans</term>
<term>Immunization Schedule</term>
<term>Immunoprophylaxis</term>
<term>Influenza</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Male</term>
<term>Prevention</term>
<term>Public health</term>
<term>Sensitivity and Specificity</term>
<term>Vaccination</term>
<term>Vaccination (standards)</term>
<term>Vaccine</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Calendrier vaccinal</term>
<term>Femelle</term>
<term>Flambées de maladies ()</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Mise en oeuvre des programmes de santé</term>
<term>Mâle</term>
<term>Organisation mondiale de la santé</term>
<term>Politique de santé</term>
<term>Recommandations comme sujet</term>
<term>Santé mondiale</term>
<term>Sensibilité et spécificité</term>
<term>Vaccination (normes)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Global Health</term>
<term>Guidelines as Topic</term>
<term>Health Plan Implementation</term>
<term>Health Policy</term>
<term>Humans</term>
<term>Immunization Schedule</term>
<term>Male</term>
<term>Sensitivity and Specificity</term>
<term>World Health Organization</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Calendrier vaccinal</term>
<term>Femelle</term>
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Immunoprophylaxie</term>
<term>Mise en oeuvre des programmes de santé</term>
<term>Mâle</term>
<term>Organisation mondiale de la santé</term>
<term>Politique de santé</term>
<term>Recommandations comme sujet</term>
<term>Santé mondiale</term>
<term>Sensibilité et spécificité</term>
<term>Vaccination</term>
<term>Grippe</term>
<term>Prévention</term>
<term>Santé publique</term>
<term>Vaccin</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Vaccination</term>
<term>Santé publique</term>
<term>Vaccin</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background. The demand for influenza vac cine is driven by recognition of its health and economic benefits. Vaccine reduces all cause mortality in the elderly by 30 to 50% and prevents ≥30% of hospital admissions for influenza related respiratory disease, heart disease and stroke. However, because most influenza vaccine (85%) is produced in only eight countries, adequate production and equitable distribution of vaccine throughout the world will pose a serious challenge when the next influenza pandemic appears. Methods. This article reviews a six point agenda for pandemic vaccination that should be undertaken during interpandemic years. The agenda includes preparing vaccine seed strains using reverse genetics, determining the characteristics of a pandemic vaccine and vaccination schedule, considering global registration of pandemic vaccines, increasing vaccination in interpandemic years, documenting the epidemiology of vaccine use and addressing political issues that will affect the global supply of pandemic vaccines. Conclusions. Planning for pandemic vaccination must begin during the interpandemic period to ensure a vaccine supply that will be adequate to meet demand in all countries. This will require the skills not only of experts in virology, epidemiology and public health but also those in politics, economics and law. The task will be complex, but its promised benefits will be immense.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
</list>
<tree><country name="France"><noRegion><name sortKey="Fedson, David S" sort="Fedson, David S" uniqKey="Fedson D" first="David S." last="Fedson">David S. Fedson</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A69 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000A69 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= France |étape= Analysis |type= RBID |clé= Pascal:04-0419609 |texte= Vaccination for pandemic influenza: a six point agenda for interpandemic years }}
This area was generated with Dilib version V0.6.34. |